3,4-dihydroxybenzylamine has been researched along with protocatechualdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FitzGerald, GB; Wick, MM | 1 |
| Sugumaran, M | 1 |
2 other study(ies) available for 3,4-dihydroxybenzylamine and protocatechualdehyde
| Article | Year |
|---|---|
Antitumor effects of biologic reducing agents related to 3,4-dihydroxybenzylamine: dihydroxybenzaldehyde, dihydroxybenzaldoxime, and dihydroxybenzonitrile.
Topics: Animals; Antineoplastic Agents; Benzaldehydes; Catechols; DNA, Neoplasm; Dopamine; Leukemia L1210; Male; Mice; Nitriles; Oximes; Ribonucleotide Reductases; Structure-Activity Relationship | 1987 |
Oxidation of 3,4-dihydroxybenzylamine affords 3,4-dihydroxybenzaldehyde via the quinone methide intermediate.
Topics: Basidiomycota; Benzaldehydes; Catechols; Chromatography, High Pressure Liquid; Dopamine; Indolequinones; Indoles; Kinetics; Monophenol Monooxygenase; Oxidation-Reduction; Quinones; Spectrophotometry; Spectrophotometry, Ultraviolet | 1995 |